Personal Factors Affecting Therapeutic Responses to BCG Vaccination in Asthmatics

다국어 초록 (Multilingual Abstract)

Purpose: Bacille Calmette-Guérin (BCG) vaccination has been reported to be an effective treatment for asthma in several animal models. This study investigated whether the response to BCG treatment in asthma depends on subject clinical characteristics. Methods: Stable asthma patients were vaccinated with BCG. One month later, alterations in pulmonary function after vaccination and their relationships with subject clinical characteristics were determined. Results: Of 149 patients with asthma, 54 (36.2%) showed a good or fair response to BCG. The ΔFEV1 after vaccination was significantly related to age (r=-0.348, P<0.001), peripheral blood eosinophil counts (r=0.315, P<0.001) and baseline FEV1, expressed as % personal best value (r=-0.474, P<0.001), but not to FEV1 % predicted value (r=-0.066, P>0.05). A good/fair response was highly prevalent in atopic females compared with atopic males, especially among those aged ≤50 years (90.9% vs. 40.0%, P=0.024). Age (P<0.001, odds ratios (OR)=0.92, confidence interval (CI)=0.88-0.96) and atopy (P<0.01, OR=4.95, CI=1.70-14.44) were significant predictors for a good/fair response in females. However, blood eosinophil counts (P<0.05, OR=1.18, CI=1.01-1.39) and FEV1 % best (P<0.001, OR=0.86, CI=0.79-0.94), but not age or atopy, were significant predictors in males. Approximately three-quarters of the males were smokers. Conclusions: The therapeutic effect of BCG in asthma may differ according to patient clinical characteristics. The greatest benefit occurred in young atopic females. Asthma activity indices, such as eosinophilia and FEV1 % best, were more predictive of a good/fair response in males; this may have been related to cigarette smoking.

참고문헌 (Reference)

1 Choi IS, "Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial" 88 : 584-591, 2002

2 Miller RA, "The aging immune system: primer and prospectus" 273 : 70-74, 1996

3 Everitt BS, "The Cambridge dictionary of statistics. 3rd ed" Cambridge University Press 2006

4 Zuany-Amorim C, "Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells" 8 : 625-629, 2002

5 Choi IS, "Strain-dependent suppressive effects of BCG vaccination on asthmatic reactions in BALB/c mice" 95 : 571-578, 2005

6 Adisesh A, "Smoking status and immunoglobulin E seropositivity to workplace allergens" 61 : 62-64, 2011

7 Lazarus SC, "Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma" 175 : 783-790, 2007

8 Crapo RO, "Reference spirometric values using techniques and equipment that meet ATS recommendations" 123 : 659-664, 1981

9 최인선, "Preventive effects of mycobacteria and their culture supernatants against asthma development in BALB/c mice" 대한천식알레르기학회 2 (2): 34-40, 2010

10 Magnusson CG, "Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy" 78 : 898-904, 1986

11 최인선, "Inoculation route-dependent and allergen-specific suppressive effects of Bacille Calmette-Guerin vaccination on asthmatic reactions in BALB/c mice" SPRINGER 185 (185): 179-186, 200706

12 Erb KJ, "Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia" 187 : 561-569, 1998

13 Legendre AM, "In vivo and in vitro responses of cats sensitized with viable Mycobacterium bovis (BCG)" 40 : 1613-1619, 1979

14 Adinoff AD, "Immediate skin test reactivity to Food and Drug Administration-approved standardized extracts" 86 : 766-774, 1990

15 Global Initiative for Asthma, "Global strategy for asthma management and prevention [Internet]"

16 최인선, "Gender-Specific Asthma Treatment" 대한천식알레르기학회 3 (3): 74-80, 2011

17 de Benedictis FM, "Gender differences in the effectiveness of asthma treatment" 121 : 1289-, 2008

18 Ownby DR, "Factors underlying the increasing incidence and prevalence of allergic diseases in Middleton’s allergy: principles & practice. 7th ed." Mosby 769-778, 2009

19 Weller PF, "Eosinophilia and eosinophil-related disorders inMiddleton’s allergy: principles & practice. 7th ed." Mosby 859-877, 2009

20 최인선, "Effects of dehydroepiandrosterone on Th2 cytokine production in peripheral blood mononuclear cells from asthmatics" 23 (23): 176-181, 2008

21 Cui Y, "Effects of combined BCG and DHEA treatment in preventing the development of asthma" TAYLOR & FRANCIS INC 37 (37): 191-202, 2008

22 Choi IS, "Effects of BCG revaccination on asthma" BLACKWELL PUBLISHING 58 (58): 1114-1116, 2003

23 Shirtcliffe PM, "Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma" 34 : 207-212, 2004

24 Scarpace PJ, "Decreased beta-adrenergic agonist affinity and adenylate cyclase activity in senescent rat lung" 38 : 143-147, 1983

25 Armanini D, "Corticosteroid receptors and aging" 45 : 191-194, 1993

26 Morris AH, "Clinical pulmonary function testing: a manual of uniform laboratory procedures. 2nd ed" Intermountain Thoracic Society 1984

27 British Thoracic Society Scottish Intercollegiate Guidelines Network, "British guidelines on the management of asthma. A national clinical guideline [Internet]"

28 최인선, "BCG-Induced Dendritic Cell Responses and Suppression of Interleukin-5 Production from T Cells in Atopic Asthmatics" 대한의학회 23 (23): 628-634, 2008

29 Herz U, "BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model" 102 : 867-874, 1998

30 Koh YI, "BCG infection during pre-sensitization or even post-sensitization inhibits airway sensitivity in an animal model of allergic asthma" 15 : 265-272, 2000

31 Major T, "Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses" 20 : 1532-1540, 2002

32 Cockcroft DW, "Airway responsiveness" Lippincott-Raven 1253-1266, 1997